Skip to main content

The Wistar Institute

|

Wistar Scientists Identify Link Between Mitochondria and Pancreatic Cancer Risk

PHILADELPHIA — (OCTOBER 12, 2022) — The mitochondria is a key energy-producing component of the human cell that plays an important role in cancer cell metabolism. In a research paper published in PLOS ONE, Dario C. Altieri, M.D., president and chief…
Read more
|

Up in (Antibody) Arms: Synthetic DNA Immunotherapy Platform Combats Brain Cancer

Researchers in the Weiner Lab developed DNA-launched bispecific T cell engagers that controlled tumor growth and improved survival in glioblastoma. Glioblastoma is one of the most severe and aggressive forms of brain cancer with limited treatment op…
Read more
|

Wistar’s Dr. Amelia Escolano Earns NIH Director’s New Innovator Award

PHILADELPHIA — (OCTOBER 4, 2022) — The National Institutes of Health has awarded Amelia Escolano, Ph.D., assistant professor in The Wistar Institute’s Vaccine & Immunotherapy Center, the 2022 NIH Director’s New Innovator Award. The honor provide…
Read more
|

Fighting Breast Cancer Disparities Through Collaboration

A decade-long collaboration between Wistar and ChristianaCare is leading to new discoveries and better treatment for triple-negative breast cancer patients. Dario C. Altieri, M.D., president, CEO, and director of the Ellen and Ronald Caplan Cancer C…
Read more
|

Supporting Science Across Borders with Student Exchange

Nestled in Northern Italy, the city of Bologna is one filled with medieval architecture, sprawling city squares, and a culture of scientific excellence. The University of Bologna is considered the oldest university in the western world and asserts a…
Read more
|

Finding Balance at the Bench

This National Postdoc Appreciation Week, we asked our postdoctoral fellows how they strive to keep balance between their research and personal lives. Wistar postdoctoral fellows serve as critical members of a principal investigator’s lab. They have…
Read more
|

Setting a Prime Example: Wistar’s Women & Science Program featuring Dr. Elizabeth Jaffee

As attendees tuned into their screens, Dr. Elizabeth Jaffee began her presentation Pancreatic Cancer Is PRIMED to Become an Immunologic Disease. With a full house of Zoomers, the Deputy Director of The Sidney Kimmel Comprehensive Cancer Center at Jo…
Read more
|

Wistar Scientists Identify Key Biomarkers that Reliably Predict Response to Immune Checkpoint Inhibitor Therapy for Melanoma

New research finds biological processes that improve prediction of therapeutic performance and provide a framework to develop predictors for this aggressive skin cancer. PHILADELPHIA — (SEPTEMBER 19, 2022) — Immune checkpoint inhibitor (ICI) therapy…
Read more
|

Unraveling The Enigmas of Melanoma

Meenhard Herlyn, D.V.M., D.Sc., is known internationally as one of the fathers of melanoma research. As the founder of The Wistar Institute Melanoma Research Center, he has led the way with breakthrough discoveries about this mysterious and hard-to-…
Read more
|

Career Spotlight: Carlos Carmona in the Montaner Lab

Recently, The Wistar Institute created a virtual tour of our Montaner Lab which focuses on infectious disease research such as HIV through highly collaborative regional and international projects. We interviewed Carlos Carmona, Data and System Manag…
Read more